US Plasma Fractionation Companies

CSL Plasma, a leading player in the market, opened a new plasma collection center in Savannah, Georgia, in September 2023. This expansion reflects the rising demand for plasma and the company's commitment to increasing donor accessibility.

Grifols, another major player, received FDA approval for its Gamunex C albumin product in August 2023. This new albumin formulation offers longer shelf life and stability, providing greater flexibility for healthcare providers.

Baxter, a well-established pharmaceutical company, entered into a plasma supply agreement with Octapharma in June 2023. This collaboration aims to secure a reliable plasma source for both companies and strengthen their positions in the market.

Kedrion Biopharma, a leading Italian player, announced new sustainability initiatives in June 2023, focusing on energy efficiency, waste reduction, and responsible sourcing of materials. This move reflects the growing focus on environmental responsibility within the plasma fractionation industry.

List of US Plasma Fractionation Key Companies in the Market

• Takeda


• CSL


• Grifols


• Octapharma


• Kedrion


• LFB Group


• Biotest


• BPL


• RAAS


• CBPO